Novo Nordisk’s stock rallied after drugmaker reveals deal with OpenAI

By:
On:
URL has been copied successfully!
Novo Nordisk is working with OpenAI on a broad deal that will use artificial intelligence to more quickly develop new medications as well as help train its workforce.
Please follow us:
Follow by Email
X (Twitter)
Whatsapp
LinkedIn
Copy link

This post was originally published here.